相关实验视频
Updated: Jun 18, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.8K
在糖尿病的云层之上:从病理生理学考虑到安全飞行的实际建议
Dimitra Vasdeki1, Georgios Tsamos1, Kleoniki I Athanasiadou2
1Division of Endocrinology and Metabolism and Diabetes Centre, First Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA University Hospital, Thessaloniki, Greece.
High altitude medicine & biology
|August 2, 2024
概括
患有糖尿病的旅行需要仔细规划. 本综述提供了在飞行期间管理糖尿病的实用建议,并讨论了飞行员的资格,确保为所有人提供更安全的航空旅行.
科学领域:
- 航空航天医学 航空航天医学
- 内分泌学 在内分泌学.
- 公共卫生 公共卫生
背景情况:
- 随着全球糖尿病患病率的增加,需要进行旅行前的医疗咨询.
- 对于糖尿病患者来说,航空旅行带来了独特的挑战,包括饮食,药物和环境因素.
- 对于患有糖尿病的飞行员的传统限制正在随着新的协议而发展.
研究的目的:
- 审查有关糖尿病和航空旅行的现有证据.
- 分析糖尿病飞行员的安全和认证.
- 为在飞行期间管理糖尿病提供实际建议.
主要方法:
- 现有文献的叙述性审查.
- 对安全和认证协议的分析.
- 综合实际的管理策略.
主要成果:
- 确定的挑战包括饮食问题,药物获取,剂量中断和低压性暴露.
- 随着法规的不断变化,糖尿病患者的飞行员可以在严格的协议下飞行.
- 技术进步和新的糖尿病药物影响管理策略.
结论:
- 对于糖尿病患者来说,安全的航空旅行需要解决特定的挑战.
- 更新的协议对于评估糖尿病飞行员的资格至关重要.
- 需要进一步的研究来填补知识空白并确保飞行安全.
相关概念视频
Diabetes: Symptoms, Diagnosis, and Complications
521
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
521
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Diabetes: Management and Pharmacotherapy
250
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
250
Pathophysiology of Diabetes
913
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
913
Hypoglycemia and Glucagon
229
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
229

